US Peripheral IV Catheters Market Growth Forecast 2023-2030: Market Set to Reach USD 9.1 Billion Fueled by Rising Cardiovascular Diseases and Geriatric Population

The Global Peripheral IV Catheters Market was valued at US$ 5.2 billion in 2022 and is projected to reach US$ 9.1 billion by 2030, registering a CAGR of 7.4% during 2023-2030. Market growth is driven by the rising prevalence of chronic and infectious diseases, increasing hospital admissions, and growing demand for reliable vascular access devices in healthcare settings.

Innovations in catheter design, including safety-engineered and antimicrobial-coated products, are improving patient safety and reducing infection risks. The expanding use of peripheral IV catheters in home healthcare and ambulatory care centers further supports market growth, as the focus shifts toward advanced, patient-centric infusion solutions.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID): https://www.datamintelligence.com/download-sample/peripheral-iv-catheters-market?sai-v

The Peripheral IV Catheters Market involves medical devices inserted into veins to deliver fluids, medications, or nutrients, essential for patient care in hospitals, clinics, and emergency settings.

Key Developments

✅ June 2025 (United States): Becton, Dickinson and Company (BD) introduced an upgraded safety-engineered peripheral IV catheter with enhanced blood control technology, aiming to reduce blood exposure and infection risk in hospitals. The device is designed to comply with the latest U.S. safety and occupational health standards.

✅ April 2025 (United States): Teleflex Incorporated expanded its catheter manufacturing capacity in North Carolina to meet growing U.S. and export demand. The expansion supports increased supply of single-use peripheral IV catheters and aligns with sustainability goals through eco-friendly production lines.

✅ May 2025 (Japan): Terumo Corporation launched a next-generation peripheral IV catheter featuring ultra-smooth insertion and antimicrobial coating to reduce phlebitis and infection rates. The device is being adopted across Japanese hospitals as part of infection prevention initiatives.

✅ February 2025 (Japan): Nipro Corporation partnered with a local academic research institute to develop smart IV catheter prototypes integrating micro-sensors for monitoring vein pressure and flow rates, aimed at improving patient safety and procedural accuracy.

Mergers & Acquisitions

✅ March 2025 (United States): Smiths Medical completed the acquisition of a U.S.-based medtech startup specializing in closed IV system designs. This move strengthens its product line in safety IV access solutions.

✅ January 2025 (Japan): A leading Japanese medical device company acquired a smaller catheter technology firm to expand its R&D capabilities in minimally invasive vascular access systems for hospitals and clinics.

Market Outlook

"Peripheral IV catheters remain a cornerstone of hospital-based care, now evolving with advanced safety and infection-control technologies."

◆ United States: Demand is driven by growing hospital admissions, rising chronic disease treatments, and the adoption of safety-engineered catheter systems compliant with FDA guidelines.

◆ Japan: Market growth is supported by strong healthcare infrastructure, increasing geriatric patient volume, and innovations in antimicrobial and smart catheter technologies.

◆ Globally, the market is set for sustained expansion through 2030, driven by infection control standards, advanced material technologies, and the integration of smart sensing in IV therapy device

Key Players:

Becton Dickinson | B. Braun Melsungen AG | Argon Medical | Vygon | ICU Medical Inc. | VOGT Medical | RenovoRx Inc. | Nipro Medical | Teleflex | Greiner Bio-One

Key Highlights:

• Becton Dickinson - Reported USD 19.5 billion in 2024, leading in medical devices and vascular access solutions.
• B. Braun Melsungen AG - Generated USD 9.0 billion, expanding its infusion therapy and surgical systems portfolio.
• Argon Medical - Estimated USD 300 million, specializing in interventional and vascular access products.
• Vygon - Achieved around USD 450 million, focusing on single-use medical and catheter devices.
• ICU Medical Inc. - Posted USD 2.4 billion, a global provider of infusion therapy and critical care systems.
• VOGT Medical - Recorded USD 150 million, offering customized medical disposables and tubing systems.
• RenovoRx Inc. - Valued at USD 40 million, focused on targeted therapy delivery for cancer treatments.
• Nipro Medical - Generated USD 3.5 billion, recognized for renal, interventional, and injection systems.
• Teleflex - Reported USD 3.7 billion, expanding in anesthesia and vascular access solutions.
• Greiner Bio-One - Achieved USD 580 million, known for pre-analytics and biotechnology applications.

Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=peripheral-iv-catheters-market?sai-v

Market Drivers & Growth:

The rising prevalence of chronic and lifestyle-related diseases, along with increasing hospitalization rates, is boosting demand for "peripheral IV catheters."

The shift toward minimally invasive procedures and outpatient care settings is expanding catheter use beyond traditional hospital environments.

Technological innovations such as safety-engineered designs, antimicrobial coatings, and ultrasound-guided insertion are enhancing patient outcomes and reducing complications.

The growth of home healthcare services and ambulatory infusion therapies is creating new opportunities for safer and shorter-dwell catheters.

The market is showing strong momentum, with rising global adoption across hospitals, clinics, and home care settings due to safety and ease-of-use advancements.

Regional Insights:

United States: Leads the global market, supported by advanced healthcare infrastructure, high procedural volumes, and strong patient safety standards.

Japan: Demonstrates steady growth driven by an aging population and the adoption of advanced vascular access technologies in hospitals.

Europe: Maintains a robust market presence due to strict healthcare regulations and continuous innovation in catheter materials and design.

Asia-Pacific: Emerging as a fast-growing region with expanding healthcare access, increasing chronic disease incidence, and the development of outpatient treatment centers in China and India.

Key Segments:

➥ By Product:
Includes Integrated/Closed PIVCs, Short PIVCs, Ported, Non-Ported, and Midline Catheters, offering flexibility for various clinical settings and patient needs.

➥ By Technology:
Covers Conventional PIVCs and Systems PIVCs, with system-based solutions gaining traction for their superior safety features and reduced contamination risk.

➥ By End User:
Majorly utilized across Hospitals, Ambulatory Surgical Centers, and Clinics, where the focus is on improving infusion therapy efficiency and minimizing catheter-related complications.

Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/peripheral-iv-catheters-market?sai-v

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.